Sign in

CIK 0001130166

  • Non-accelerated filer
  • Smaller reporting company

Bio Green Med Solution, Inc.

Sign in to watch
Tickers
BGMS BGMSP
Exchange
Nasdaq, OTC
Industry
Wholesale-Durable Goods, NEC
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
911766850
Phone
+1 908-517-7330
Business address
200 CONNELL DRIVE, SUITE 1500, BERKELEY HEIGHTS, NJ, 07922
Former names
Cyclacel Pharmaceuticals, Inc., XCYTE THERAPIES INC

Securities

  • BGMS Common Stock Nasdaq
  • BGMSP Common stock OTC
  1. 4 Open-market sale VP, Sales & Marketing sold 10,000 shares at $2.50 ($25,000)
  2. 4 Open-market sale President & C.E.O. sold 8,350 shares at $2.50 ($20,875)
  3. 4 Derivatives Options or other derivatives
  4. 4 Derivatives Options or other derivatives
  5. 4 Derivatives Options or other derivatives
  6. 4 Derivatives Options or other derivatives
  7. 4 Derivatives Options or other derivatives
  8. 4 Open-market sale 10% owner sold 232,487 shares at $1.54 ($358,030)
  9. 3/A Insider 3/A
  10. 4 Open-market sale 10% owner sold 108,900 shares at $1.14 ($124,288)
  11. 4 Open-market sale 10% owner sold 1,209,400 shares at an average $1.25 ($1,514,398)
  12. 4/A Grant or award V.P., Clin. Dev. & Reg. Aff. acquired 25,000 shares (grant or award)
  13. 4/A Grant or award President & C.E.O. acquired 50,000 shares (grant or award)
  14. 4 Open-market sale 10% owner sold 328,850 shares at $0.80 ($263,080)
  15. 4 Open-market sale 10% owner sold 71,150 shares at $0.86 ($61,189)
  16. 4 Open-market sale 10% owner sold 103,172 shares at $0.88 ($90,791)
  17. 4 Open-market buy 10% owner bought 4,300 shares at $0.87 ($3,741)
  18. 4 Open-market buy 10% owner bought 1,000 shares at $0.84 ($840)
  19. 4 Open-market buy 10% owner bought 57,200 shares at $0.90 ($51,480)
  20. 4 Open-market buy 10% owner bought 5,900 shares at $0.84 ($4,956)

Page 12 of 26 · 511 filings